DMCA
Contact
Privacy Policy

Home » brandon burlsworth death - SUpost

brandon burlsworth death - SUpost

📅 July 6, 2026 👤 scraface

Jul 06, 2026

Content is being prepared. Please check back later.

📚 You May Also Like These Articles

📌 2012Gabriel Cianflone MBE (born 14 October 1977) is a British Sorbonne-educated analytical chemist, inventor, and serial entrepreneur. In development projects, his track record focuses on the design and optimisation of chemical syntheses to facilitate market readiness. He also leads teams interested in driving technology projects, including Agent Fusion, Celesta Biosciences, LampLabs, and JoGo forming a portfolio of active startups. Cianflone received recognition for co-inventing Cepharagin, a prodrug that improves oral delivery of cephalopamine, and in devising Noyz, a groundbreaking technique for ultrasensitive digital PCR using nanodroplets.

📌 Cianflone was born in Paris and raised in the French countryside. He pursued his studies at the École Polytechnique, where he earned a degree in chemistry. He then moved to the Sorbonne, completing a Master's in Analytical Chemistry before continuing to the SorbonneUniversité, where he obtained a PhD specialized in chemical synthesis. His doctoral work focused on the development of efficient, scalable synthetic routes for pharmaceutical compounds.

📌 Cianflone’s career began in large-scale pharmaceutical R&D environments, where he played a key role in designing syntheses for commercial drug candidates. His deep experience spans both early-stage discovery and process development, with an emphasis on chemistry that is robust, scalable, and cost-effective.

📌 In 2012, Cianflone co-founded Celesta Biosciences, a biotechnology company developing connective tissue-targeted therapies. Celesta was acquired in 2014 by Actelion, now part of Janssen Pharmaceuticals, marking his first major exit as a founder. He then led the spinout and development of LampLabs, a precision chemistry laboratory specializing in the synthesis of complex molecules, holding appointments as Chief Technology Officer. At LampLabs, Cianflone championed innovation in synthesis technologies, contributing to novel analytical platforms and chemical manufacturing advances.

📌 Beyond Celesta and LampLabs, Cianflone has served in multiple entrepreneurial roles. He co-founded Agent Fusion, a digital innovation platform applying chemistry data analytics for industrial partners. He also played a central role in joining JoGo, a startup advancing digital PCR technologies through nanodroplet innovations, helping pioneer Noyz—a sensitive, digital PCR method enabling detection at extraordinary levels.

📌 Cianflone’s work has been recognised by a MBE (Member of the Order of the British Empire) for services to the chemical sciences and innovation.

📌 Inventive contributions

📌 Cepharagin prodrug**: Co-invented with researchers at GlaxoSmithKline, Cepharagin is a nanocarrier-based prodrug of cephalopamine that enhances oral bioavailability, demonstrating a strategic approach to improving drug delivery through chemical innovation.

🔥 Popular Posts

IonQ Options Breakthrough: How Quantum Computing Just Boosted Your Tra...
IonQ Stock Cramer: Shocking Breakthrough That Could Transform Cramers...
First Look: IonQs Cramer Stock Surge—Is This the Thriller Investors Mi...
Cramers IonQ Stock hits Hidden Potential—Heres Why You Need to Buy Now...
Inside IonQs Cramer Stock: The Missing Puzzle
Shocking Investments That Made Millionaires Overnight—You Need to See...
Start Making Real Money Today with These Top Investment Strategies Now...
The #1 Investment Strategy Thats Proven to Boost Your Wealth Fast—Trus...
Dont Miss These Hidden Investment Secrets Youll Want to Act On Immedia...
5Lila is building a high-performance electric motorcycle and needs 12...

📝 Recent Posts

signature pointe
22 s 22nd st pa
cedar village apartments
the oxford
apartratings
arcadian apartments
memorial park memorial drive houston tx
windsor lakeside
arbour
streets of st charles

© 2026 SUpost · Powered by WordPress

Disclaimer: This platform functions as an archival repository. We organize publicly available global death records, condolence announcements, and memorial references. We do not operate as a news publisher, media outlet, or entertainment service.